A Case of Sorafenib-induced DRESS Syndrome in Hepatocelluar Carcinoma

A Case of Sorafenib-induced DRESS Syndrome in Hepatocelluar Carcinoma

Sorafenib is currently the only targeted therapy available for advanced stage hepatocellular carcinoma (HCC). Cutaneous adverse events associated with sorafenib treatment include hand-foot skin reaction, but there has been no report of drug reaction (or rash) with eosinophilia and systemic symptoms...

Full description

Bibliographic Details
Main Authors: Dong Kyun Kim, Sung Woo Lee, Hwa Seong Nam, Dong Sub Jeon, Na Rae Park, Young Hee Nam, Soo Keol Lee, Yang Hyun Baek, Sang Young Han, Sung Wook Lee
Format: Article
Language:English
Published: Jin Publishing & Printing Co. 2016-06-01
Series:The Korean Journal of Gastroenterology
Subjects:
DRESS syndrome
Sorafenib
Hepatocellular carcinoma
Online Access:http://www.kjg.or.kr/journal/view.html?doi=10.4166/kjg.2016.67.6.337

Similar Items

Similar Items